119th Congress
S. 3510
Biosimilar Inspection Modernization Act of 2025
- Introduced
- In committee
- Passed Senate
- Passed House
- To President
- Became law
- Sponsor
- Ted Budd(R-NC)
- Introduced
- Dec 16, 2025
- Policy area
- Health
- Committees
- Senate Committee on Health, Education, Labor, and Pensions
- Official text
- Introduced in Senate · Congress.gov page
Cosponsors (1)
Original cosponsors (1)
- Margaret Wood Hassan (D-NH)
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: A bill to improve the inspections of drug establishments engaged in the manufacture, preparation, propagation, or processing of biosimilar biological products conducted by the Food and Drug Administration, and for other purposes.
Latest action(Dec 16, 2025): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Roll-call votes
No recorded votes on this bill.
Actions
- Dec 16, 2025 · Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. - Dec 16, 2025
Introduced in Senate